Paul M. Mendelman
Plus aucun poste en cours
Profil
Paul M.
Mendelman worked as a Director of Clinical Research Infectious Diseases at Merck & Co., Inc. from 1991 to 1996.
He then worked as a Vice President of Clinical Development at MedImmune LLC from 2002 to 2005.
He also held the position of Vice President of Clinical Development at MedImmune Vaccines, Inc. and Senior Vice President of Clinical Development at Telik, Inc. He was the Chief Medical Officer & EVP at LigoCyte Pharmaceuticals, Inc. and later became the Chief Medical Officer at Aridis Pharmaceuticals, Inc. He returned to Aridis Pharmaceuticals, Inc. in 2019 as the Chief Medical Officer until 2020.
From 2012 to 2017, he worked as the Vice President of Medical at Takeda Vaccines, Inc. Dr. Mendelman received his undergraduate and doctorate degrees from The Ohio State University.
Anciens postes connus de Paul M. Mendelman
| Sociétés | Poste | Fin |
|---|---|---|
| ARIDIS PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 15/06/2020 |
Takeda Vaccines, Inc.
 Takeda Vaccines, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Vaccines, Inc. provides biological research and development services. The company is based in Bozeman, MT. | Corporate Officer/Principal | 01/01/2017 |
| LigoCyte Pharmaceuticals, Inc. | Directeur Technique/Scientifique/R&D | 16/04/2014 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | 01/01/2005 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/1996 |
Formation de Paul M. Mendelman
| The Ohio State University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ARIDIS PHARMACEUTICALS, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Telik, Inc.
 Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA. | Health Technology |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
MedImmune Vaccines, Inc.
 MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Health Technology |
| LigoCyte Pharmaceuticals, Inc. | Health Technology |
Takeda Vaccines, Inc.
Takeda Vaccines, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Vaccines, Inc. provides biological research and development services. The company is based in Bozeman, MT. | Commercial Services |
